Mary Kirby

Armodafinil and Modafinil Have Substantially Different Pharmacokinetic Profiles Despite Having the Same Terminal Half-Lives

Mona Darwish, Mary Kirby, Edward T. Hellriegel et al. · Clinical Drug Investigation · 2009 · 256 citations

Pharmacy, Pharmacokinetics, Pharmacology +11

Absolute and Relative Bioavailability of Fentanyl Buccal Tablet and Oral Transmucosal Fentanyl Citrate

Mona Darwish, Mary Kirby, Philmore Robertson et al. · The Journal of Clinical Pharmacology · 2007 · 101 citations

Pharmacy, Pharmacokinetics, Pharmacology +17

Pharmacokinetics and Dose Proportionality of Fentanyl Effervescent Buccal Tablets in Healthy Volunteers

Mona Darwish, Kenneth F. Tempero, Mary Kirby et al. · Clinical Pharmacokinetics · 2005 · 55 citations

Pharmacy, Pharmacokinetics, Pharmacology +12

Relative bioavailability of the fentanyl effervescent buccal tablet (FEBT) 1080 pg versus Oral transmucosal fentanyl citrate 1600 pg and dose proportionality of FEBT 270 to 1300 μg: A single-dose, randomized, open-label, three-period study in healthy adult volunteers

Mona Darwish, Kenneth F. Tempero, Mary Kirby et al. · Clinical Therapeutics · 2006 · 52 citations

Pharmacy, Pharmacokinetics, Pharmacology +17

Pharmacokinetic properties of fentanyl effervescent buccal tablets: A phase I, open-label, crossover study of single-dose 100, 200, 400, and 800 μg in healthy adult volunteers

Mona Darwish, Mary Kirby, Philmore Robertson et al. · Clinical Therapeutics · 2006 · 45 citations

Pharmacy, Pharmacokinetics, Pharmacology +13